Skip to Content

CellCept 250 Roche (Cellcept 250 mg)

Generic Name: mycophenolate mofetil

Pill imprint CellCept 250 Roche has been identified as Cellcept 250 mg.

CellCept is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. CellCept 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cellcept 250 mg CellCept 250 Roche
Cellcept 250 mg CellCept 250 Roche Front
Cellcept 250 mg CellCept 250 Roche Back
Cellcept 250 mg CellCept 250 Roche
Generic Name:
mycophenolate mofetil
CellCept 250
250 mg
Orange & Turquoise
19.00 mm
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Roche Laboratories
National Drug Code (NDC):
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
povidone k90
corn starch
ferrosoferric oxide
FD&C Blue No. 2
ferric oxide yellow
ferric oxide red
titanium dioxide
silicon dioxide
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68258-9073 Dispensing Solutions Inc. (repackager)
21695-0171 Rebel Distributors Corp (repackager)
49999-0936 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.